7[1]Antoniou D, Ziras N, Karydis I, et al. Comparative analysis of different regimens of first-line chemotherapy in 784 inoperable non-small cell lung cancer patients. Proceeding of ASCO,2001,20∶338a.
8[2]Danson S, Clemons M, Middleton M, et al. A randomized study of gemcitabine with carboplatin versus mitomycin C, vinblastine and cisplatin or mitomycin C, ifosfamide and cisplatin as first line chemotherapy in advanced non-small cell lung cancer. Proceeding of ASCO,2001,20∶322a.
9[3]Fukuoka M, Negoro S, Masuda N, et al. Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase Ⅱ study. Am J Clin Oncol,1992,15(1)∶18-22.
10[4]Ellis PA, Smith IE, Hardy JR, et al. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br J Cancer,1995,71(2)∶366-370.
